Search results for: 'salesforce complex landscape'

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

This research service analyzes key data and provides an in-depth analysis of the US cardiac ablation market. The segments covered include catheter ablation, surgical ablation, and cardiac mapping. The major topics explored in this study include the most significant products marketed by top participants, cost analysis, competitive playbook, regulato...

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

01 Jun 2020  |  North America  |  Market Research

Growth Opportunities in Artificial Intelligence and Analytics in Surgery, 2020

Landscape and Opportunity Assessment in an Emerging Area

Infographics

×

Key Issues Addressed

Artificial intelligence (AI) and analytics technologies are now being well accepted in healthcare, with bellwether clinical application areas (e.g., radiology), and operational application areas (e.g., revenue cycle management). One area of the hospital that perhaps needs the most attention, is the hospital operating room (OR). The OR is a hospital...

14 Jun 2021  |  North America  |  Market Research

Growth Opportunities for MedTech in the Transformation of the US Healthcare Provider Ecosystem

Transformational Growth in the Care Delivery Landscape is Changing Health Systems into Systems of Health

Infographics

×

Healthcare providers are on the verge of reinventing their role in the care delivery process due to various external factors, such as the following: • Unsustainable growth in healthcare spending driving continuous downward pressure and declining operating margins • The emergence of alternative payment models that focus on patient outcome and re...

Advanced visualization and robotic tools during the pre-operative and intraoperative phases of a procedure allow surgeons to identify and localize targets so that they can navigate and perform complex surgeries with precision, minimizing invasiveness, improving recovery times, and lowering the risk of post-procedure complications. This Frost & ...

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

04 Aug 2021  |  North America  |  Market Research

Growth Opportunities Arising due to the Use of Commercial AI Models in Radiology

The Intensely Competitive Landscape Necessitates the Repositioning of Value Through the Acceptance of New Business Models

Infographics

×

As artificial intelligence (AI) solutions gain acceptance in the imaging fraternity and among senior leaders in the health systems space, competition has intensified and necessitated the creation of differentiation strategies for companies that want to improve their revenue and sustain growth. The rapid proliferation of medical imaging AI companies...

As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules, cell and gene therapies (CGT), and mRNA therapies, it is imperative for pharma sponsors to pursue partnerships to gain technology access, database generation and analysis, and pre-clinical and clinical research. Furt...